Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: 5-Hydroxytryptophan and Carbidopa

Research Papers that Mention the Interaction

On two different days, we measured blood cortisol level every 15 min for 4 h following the ingestion of L-5-HTP , 0.4 mg/kg, or placebo, both given with carbidopa , a peripheral tryptophan decarboxylase inhibitor, used to prevent peripheral L-5-HTP metabolism before brain absorption.
Chest  •  1997  |  View Paper
L-5-HTP with carbidopa dramatically decreased the frequency and intensity of myoclonus, particularly in those patients with a diagnosis of postanoxic intention myoclonus.
Monographs in neural sciences  •  1976  |  View Paper
When L-tryptophan or 5-hydroxytryptophan is administered with phenelzine (a monoamine oxidase inhibitor) and carbidopa (a selective peripheral L-amino acid decarboxylase inhibitor) to raise brain serotonin, a significant increase in myocardial electrical stability is observed.
Federation proceedings  •  1986  |  View Paper
In addition, the authors started 5-hydroxytryptophan titrated to 400 mg orally twice daily with concomittant carbidopa 37.5 mg orally four times a day, and he responded with remission of suicidal ideation and significant improvement in depression and function.
BMJ Case Reports  •  2011  |  View Paper
L-5-Hydroxytryptophan , a precursor of serotonin, increases serotonin turnover in the central nervous system when given after carbidopa.
Archives of general psychiatry  •  1992  |  View Paper
We report a case of scleroderma-like illness with unusual pseudobullous morphea and eosinophilia in a patient receiving L-5-hydroxytryptophan and carbidopa
Journal of the American Academy of Dermatology  •  1991  |  View Paper
L-5HTP treatment with and without carbidopa administration increased b-EP levels significantly (p < 0.05).
Cephalalgia : an international journal of headache  •  1986  |  View Paper
On a regimen of 1 g L-5-HTP and 100 mg l-alpha-methyldopa hydrazine ( carbidopa ), action myoclonus disappeared completely.
Advances in neurology  •  1986  |  View Paper
The plasma concentrations of 5-hydroxytryptophan were increased about ten fold by pretreatment with the decarboxylase inhibitors, carbidopa and benserazide.
Acta pharmacologica et toxicologica  •  1978  |  View Paper
1-3 In 18 patients with intention myoclonus either due to anoxia or other brain damage, we observed that 61% derived a greater than 50% overall improvement during treatment with L-5HTP in combination with carbidopa.
Archives of neurology  •  1977  |  View Paper
Show More